A systematic review and methodological evaluation of published cost-effectiveness analyses of aromatase inhibitors versus tamoxifen in early stage breast cancer.

<h4>Background</h4>A key priority in developing policies for providing affordable cancer care is measuring the value for money of new therapies using cost-effectiveness analyses (CEAs). For CEA to be useful it should focus on relevant outcomes and include thorough investigation of uncert...

Full description

Saved in:
Bibliographic Details
Main Authors: Ava A John-Baptiste, Wei Wu, Paula Rochon, Geoffrey M Anderson, Chaim M Bell
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0062614&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!